Literature DB >> 24516476

Psychotropic medication monitoring checklists: use and utility for children in residential care.

Ajit Ninan1, Shannon L Stewart1, Laura Theall1, Gillian King2, Ross Evans1, Philip Baiden1, Al Brown1.   

Abstract

OBJECTIVE: To develop side effect (SE) monitoring checklists for four categories of psychotropic medications (antipsychotics, mood stabilizers, stimulants, and selective serotonin-reuptake inhibitors), to improve residential direct care staff's confidence and competence in SE monitoring, and to facilitate communication of potential observed SE to medical personnel (e.g., nurse, physician).
METHODS: Seventy-two staff members (three nurses, 69 child/youth workers) from five residential units at a tertiary mental health centre utilized the Psychotropic Medication Monitoring Checklists (PMMC) for eight weeks and completed pre- and post-test measures of staff characteristics and PMMC satisfaction.
RESULTS: The use of PMMC led to significant changes in direct care staff's awareness and beliefs associated with medication monitoring. An increase in staff-physician communication with direct care staff was marginally significant. Further investigation into the educational qualities of the PMMC revealed that staff with very little prior formal medication education showed greater change compared to those staff reporting greater formal medication instruction. Staff ratings of the PMMC exceeded mild levels of satisfaction, indicating that the checklists were a well-received and useful tool for monitoring SE in a residential care setting.
CONCLUSIONS: The PMMC are useful as an educational SE monitoring tool for direct care staff in child residential care settings, with potential utility for multiple types of healthcare settings.

Entities:  

Keywords:  children; psychotropic medication monitoring checklist; residential care; side effects

Year:  2014        PMID: 24516476      PMCID: PMC3917668     

Source DB:  PubMed          Journal:  J Can Acad Child Adolesc Psychiatry        ISSN: 1719-8429


  13 in total

Review 1.  Atypical antipsychotic medications in the management of disruptive behaviors in children: safety guidelines and recommendations.

Authors:  Cliff McKinney; Kimberly Renk
Journal:  Clin Psychol Rev       Date:  2010-11-18

2.  National trends in child and adolescent psychotropic polypharmacy in office-based practice, 1996-2007.

Authors:  Jonathan S Comer; Mark Olfson; Ramin Mojtabai
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2010-09-01       Impact factor: 8.829

3.  National trends in the use of psychotropic medications by children.

Authors:  Mark Olfson; Steven C Marcus; Myrna M Weissman; Peter S Jensen
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2002-05       Impact factor: 8.829

4.  A naturalistic study of medication reduction in a residential treatment setting.

Authors:  Daniel F Connor; Thomas J McLaughlin
Journal:  J Child Adolesc Psychopharmacol       Date:  2005-04       Impact factor: 2.576

5.  Practice parameter on the use of psychotropic medication in children and adolescents.

Authors:  John Walkup
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2009-09       Impact factor: 8.829

Review 6.  An overview of obesity in children with psychiatric disorders taking atypical antipsychotics.

Authors:  Lauren Shin; Hallie Bregman; Jean Frazier; Nancy Noyes
Journal:  Harv Rev Psychiatry       Date:  2008       Impact factor: 3.732

Review 7.  How can we improve the assessment of safety in child and adolescent psychopharmacology?

Authors:  Benedetto Vitiello; Mark A Riddle; Laurence L Greenhill; John S March; Jerome Levine; Russell J Schachar; Howard Abikoff; Julie M Zito; James T McCracken; John T Walkup; Robert L Findling; James Robinson; Thomas B Cooper; Mark Davies; Elena Varipatis; Michael J Labellarte; Lawrence Scahill; Lisa Capasso
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2003-06       Impact factor: 8.829

8.  Survey of atypical antipsychotic prescribing by Canadian child psychiatrists and developmental pediatricians for patients aged under 18 years.

Authors:  Tamison Doey; Kenneth Handelman; Jamie A Seabrook; Margaret Steele
Journal:  Can J Psychiatry       Date:  2007-06       Impact factor: 4.356

Review 9.  Under-reporting of adverse drug reactions : a systematic review.

Authors:  Lorna Hazell; Saad A W Shakir
Journal:  Drug Saf       Date:  2006       Impact factor: 5.228

10.  Off-label psychopharmacologic prescribing for children: history supports close clinical monitoring.

Authors:  Julie M Zito; Albert T Derivan; Christopher J Kratochvil; Daniel J Safer; Joerg M Fegert; Laurence L Greenhill
Journal:  Child Adolesc Psychiatry Ment Health       Date:  2008-09-15       Impact factor: 3.033

View more
  1 in total

1.  Adverse effects of psychotropic medications in children: predictive factors.

Authors:  Ajit Ninan; Shannon L Stewart; Laura A Theall; Shehan Katuwapitiya; Chester Kam
Journal:  J Can Acad Child Adolesc Psychiatry       Date:  2014-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.